Find Pyruvate Dehydrogenase Inhibitor, Pyrimidine Synthesis Inhibitor, Liver-Targeting Inhibitor on Industry Directory, Reliable Manufacturer/Supplier/Factory from China.

Inquiry Basket (0)
Home > Products > Metabolism > Dehydrogenase Inhibitor > Mycophenolate Mofetil 128794-94-5

Mycophenolate Mofetil 128794-94-5

Product Description

.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}


Molecular Weight:

433.49 Mycophenolate Mofetil is a non-competitive, selective and reversible inhibitor of inosine monophosphate dehydrogenase I/II with IC50 of 39 nM and 27 nM, respectively.






Biological Activity


Mycophenolate mofetil is an ester prodrug of the active
immunosuppressant mycophenolic acid (MPA). The latter shows a
noncompetitive, selective and reversible inhibition activity against
inosine monophosphate dehydrogenase type I/II with IC50 of 39 nM and 27
nM, respectively. Moreover, MPA also produces the
concentration-dependent inhibition of proliferation of ConA-stimulated T
cells, LPS-stimulated B cells and alloantigen-specific T cells with
IC50 of 100 nM, 120 nM, and 51 nM, respectively.


Mycophenolate mofetil with high concentration of 10 μg/mL induces a
strong Apoptosis in microglial cell cultures and increases the number of
activated caspase-3 immunoreactive apoptotic cells. In addition,
Mycophenolate mofetil (1 μg/mL) strongly inhibits proliferation of both
microglial cells and astrocytes. A recent study shows
that Mycophenolate mofetil significantly attenuates the extent of
neuronal cell death of organotypic hippocampal slice cultures after
neuronal injury in a time-dependent manner.


In an ACI-to-Lewis rat heterotopic cardiac transplant model, treatment
of Mycophenolate mofetil at doses of 20 mg/kg and 40 mg/kg leads to a
prolongation of graft survival, with median survival time (MST) of 14.5
days and 18.5 days, respectively. In bleomycin
(BLM)-induced scleroderma mouse model, Mycophenolate mofetil reduces
inflammatory-cell infiltration, tissue hydroxyproline content and dermal
thickness.

Contact us if you need more details on 128794-94-5. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Mycophenolate Mofetil 128794-94-5、128794-94-5 Mycophenolate Mofetil. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Metabolism > Dehydrogenase Inhibitor